Pharmaceutical Manufacturing and Supply

The contract involves the manufacture and supply of oral contraceptive tablets containing 1 milligram of Norethindrone and 20 micrograms of Ethinyl Estradiol, packaged in a specific regimen of 21 tablets per cycle with five cycles per package, totaling 105 tablets per unit. All products must comply with the rigorous technical and quality standards set by the U.S. Food and Drug Administration and the Defense Logistics Agency to ensure safety, efficacy, and consistency for military and federal healthcare use. The manufacturing process must adhere to current Good Manufacturing Practices, including proper documentation, batch traceability, and stability testing, to meet regulatory and contractual obligations. This is a subcontract under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing, issued by the Department of Defense’s Medical Supply Chain Pharm FSA. The solicitation was posted on May 8, 2026, with a response deadline of May 13, 2026, indicating a narrow window for bidder submission. The place of performance and point of contact details are not specified, but delivery is expected to support federal medical supply chains, likely for distribution through military health services. Bidders must be prepared to demonstrate capacity for scalable production, adherence to federal pharmaceutical compliance guidelines, and the ability to meet strict packaging and labeling requirements as mandated by DLA and FDA.